Target intelligence / Profile preview

Gastrointestinal Pathogenic Bacteria (None)

Target
None
Molecular classification
Bacteria, Gram-negative bacteria, Pathogens
01

Overview

Gastrointestinal pathogenic bacteria are a diverse group of microorganisms capable of causing disease in the human digestive tract. Key features enabling these bacteria to cause disease include adhesion molecules, toxin production, and, in some cases, invasion capabilities. They are commonly transmitted via the fecal–oral route and can lead to various clinical syndromes ranging from mild diarrhea to severe complications like hemolytic uremic syndrome. Effective treatment is complicated by increasing antibiotic resistance.

Other names
Enteric PathogensE. coli (pathogenic strains)Diarrheagenic E. coliIntestinal Pathogens
02

Mechanism of action

Antibiotics target bacterial cell wall synthesis, DNA replication, protein synthesis, or metabolic pathways. Bismuth subsalicylate reduces inflammation and inhibits bacterial adhesion. Probiotics promote beneficial gut microbiota to compete with pathogens.

03

Biological functions

ColonizationToxin productionInvasionAdhesionNutrient acquisitionReplication
04

Disease associations

InfectionGastroenteritisDiarrheaDysenteryHemolytic Uremic Syndrome (HUS)Hemorrhagic ColitisTraveler's DiarrheaInflammation
05

Safety considerations

Antibiotic resistanceOvergrowth of opportunistic pathogens (e.g., Clostridium difficile)Side effects of antibiotics (e.g., nausea, diarrhea)Hemolytic Uremic Syndrome (HUS) associated with EHECDehydrationSepsis
06

Interacting drugs

Antibiotics (e.g., Ciprofloxacin, Azithromycin)

2 more in the full profile.

07

Biomarkers

Fecal bacterial cultureShiga toxin detectionPCR for virulence genes (e.g., stx1, stx2, eae)Fecal leukocytesLactoferrin

Beyond the preview

Go deeper on Gastrointestinal Pathogenic Bacteria (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal Pathogenic Bacteria (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call